The APPROACH Extension Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx)

ISIS 304801-CS7, The APPROACH Open Label Extension Study Volanesorsen (ISIS 304801) An Open-Label Extension Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)

This study is a multi-center, open-label extension study for ISIS 304801-CS6. All patients will receive volanesorsen 300 mg once per week for 52 weeks. Following the Week 52 visit, patients will enter a 13 week post-treatment evaluation period.

Learn More

Please complete the form below if you are interested in joining a clinical study. Please note that not all who apply are accepted into a trial.


Sign up with your name and email address to obtain ongoing updates. Please know that you can ‘opt out’ at any time.

Get In Touch

We’d love to hear from you!

Excel Medical Clinical Trials LLC
7900 Glades Road, Suite 400
Boca Raton, FL 33434